CN Patent

CN102362866A — 一种治疗糖尿病及肥胖症的药物组合物

Assigned to Individual · Expires 2012-02-29 · 14y expired

What this patent protects

本发明属于药物制剂技术领域，具体涉及一种治疗糖尿病及肥胖症的药物组合物及其制剂和用途，其特征在于单剂量药物活性成分组成为以西他列汀计西他列汀或其盐10-90mg、辛伐他汀或洛伐他汀5-50mg，优选西他列汀或其盐25-50mg、辛伐他汀或洛伐他汀5-25mg。该药物组合物可制备成任何药剂学上可接受的剂型，优选口服固体制剂。

USPTO Abstract

本发明属于药物制剂技术领域，具体涉及一种治疗糖尿病及肥胖症的药物组合物及其制剂和用途，其特征在于单剂量药物活性成分组成为以西他列汀计西他列汀或其盐10-90mg、辛伐他汀或洛伐他汀5-50mg，优选西他列汀或其盐25-50mg、辛伐他汀或洛伐他汀5-25mg。该药物组合物可制备成任何药剂学上可接受的剂型，优选口服固体制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN102362866A
Jurisdiction
CN
Classification
—
Expires
2012-02-29
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.